Product Images Lisdexamfetamine Dimesylate
View Photos of Packaging, Labels & Appearance
- Chemical Structure - lisdexamfetamine dimesylate 1
- PRINCIPAL DISPLAY PANEL - 10 mg Capsules - lisdexamfetamine dimesylate 10
- PRINCIPAL DISPLAY PANEL - 20 mg Capsules - lisdexamfetamine dimesylate 11
- PRINCIPAL DISPLAY PANEL - 30 mg Capsules - lisdexamfetamine dimesylate 12
- PRINCIPAL DISPLAY PANEL - 40 mg Capsules - lisdexamfetamine dimesylate 13
- PRINCIPAL DISPLAY PANEL - 50 mg Capsules - lisdexamfetamine dimesylate 14
- PRINCIPAL DISPLAY PANEL - 60 mg Capsules - lisdexamfetamine dimesylate 15
- PRINCIPAL DISPLAY PANEL - 70 mg Capsules - lisdexamfetamine dimesylate 16
- Figure 1 - lisdexamfetamine dimesylate 2
- Figure 2 - lisdexamfetamine dimesylate 3
- Figure 3 - lisdexamfetamine dimesylate 4
- Figure 4 - lisdexamfetamine dimesylate 5
- Figure 5-1 - lisdexamfetamine dimesylate 6
- Figure 6 - lisdexamfetamine dimesylate 7
- Figure 7 - lisdexamfetamine dimesylate 8
- Figure 8 - lisdexamfetamine dimesylate 9
Product Label Images
The following 16 images provide visual information about the product associated with Lisdexamfetamine Dimesylate NDC 0406-5111 by Specgx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - lisdexamfetamine dimesylate 1
PRINCIPAL DISPLAY PANEL - 10 mg Capsules - lisdexamfetamine dimesylate 10
PRINCIPAL DISPLAY PANEL - 20 mg Capsules - lisdexamfetamine dimesylate 11
PRINCIPAL DISPLAY PANEL - 30 mg Capsules - lisdexamfetamine dimesylate 12
PRINCIPAL DISPLAY PANEL - 40 mg Capsules - lisdexamfetamine dimesylate 13
PRINCIPAL DISPLAY PANEL - 50 mg Capsules - lisdexamfetamine dimesylate 14
PRINCIPAL DISPLAY PANEL - 60 mg Capsules - lisdexamfetamine dimesylate 15
PRINCIPAL DISPLAY PANEL - 70 mg Capsules - lisdexamfetamine dimesylate 16
Not available.*
Figure 1 - lisdexamfetamine dimesylate 2
Special Population: This description provides information regarding a special population. It includes details about gender (male/female), age (6578 years and >=75 years), renal impairment (mild, moderate, severe, end-stage renal disease), and various measurements such as PK, Coms, AUC, Coue, G, Come, and Fold Change. Additionally, it mentions 90% confidence intervals and a change relative to reference. However, the text seems to be incomplete or garbled, making it difficult to ascertain the full meaning or purpose of these details.*
Figure 2 - lisdexamfetamine dimesylate 3
Figure 3 - lisdexamfetamine dimesylate 4
Figure 4 - lisdexamfetamine dimesylate 5
Figure 5-1 - lisdexamfetamine dimesylate 6
Figure 6 - lisdexamfetamine dimesylate 7
Not available.*
Figure 7 - lisdexamfetamine dimesylate 8
Figure 8 - lisdexamfetamine dimesylate 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
